tiprankstipranks
Halozyme Therapeutics (DE:RV7)
:RV7
Germany Market

Halozyme (RV7) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Halozyme Therapeutics’s (RV7) Moving Averages Convergence Divergence (MACD) indicator is 0.55, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (RV7) 20-Day exponential moving average is 55.04, while Halozyme Therapeutics’s (RV7) share price is €55.64, making it a Buy.
Halozyme Therapeutics’s (RV7) 50-Day exponential moving average is 53.41, while Halozyme Therapeutics’s (RV7) share price is €55.64, making it a Buy.

Halozyme (RV7) Pivot Points

Mar 11, 2025, 07:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
54.98
54.98
54.98
54.98
54.98
54.98
54.98
Fibonacci
54.98
54.98
54.98
54.98
54.98
54.98
54.98
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (RV7) Moving Averages

Mar 11, 2025, 07:14 PM
Period
Simple
Exponential
MA5
55.44Buy
55.33Buy
MA10
55.34Buy
55.31Buy
MA20
55.35Buy
55.04Buy
MA50
53.14Buy
53.41Buy
MA100
50.44Buy
51.65Buy
MA200
50.40Buy
49.19Buy
Halozyme Therapeutics’s (RV7) 10-Day exponential moving average is 55.31, while Halozyme Therapeutics’s (RV7) share price is €55.64, making it a Buy.
Halozyme Therapeutics’s (RV7) 100-Day exponential moving average is 51.65, while Halozyme Therapeutics’s (RV7) share price is €55.64, making it a Buy.
Halozyme Therapeutics’s (RV7) stock price is €55.64 and Halozyme Therapeutics’s (RV7) 50-day simple moving average is 53.14, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €55.64 and Halozyme Therapeutics’s (RV7) 100-day simple moving average is 50.44, creating a Buy signal.
Halozyme Therapeutics’s (RV7) stock price is €55.64 and Halozyme Therapeutics’s (RV7) 200-day simple moving average is 50.40, creating a Buy signal.

Halozyme (RV7) Technical Indicators

Mar 11, 2025, 07:14 PM
Name
Value
Implied Action
RSI (14)
56.80
Neutral
STOCH (9,6)
21.63
Neutral
STOCHRSI (14)
33.12
Neutral
MACD (12,26)
0.55
Buy
ADX (14)
15.42
Buy
Williams %R
-48.67
Buy
CCI (14)
46.30
Neutral
ATR (14)
0.62
-
Ultimate Oscillator
52.57
Neutral
ROC
-0.82
Sell
Halozyme Therapeutics’s (RV7) Relative Strength Index (RSI) is 56.80, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Trend Strength Indicator (ADX) is 15.42, creating a Buy signal.
Halozyme Therapeutics’s (RV7) Commodity Channel Index (CCI) is 46.30, creating a Neutral signal.
Halozyme Therapeutics’s (RV7) Price Rate of Change (ROC) is -0.82, creating a Sell signal.

FAQ

Is RV7 a Buy, Hold, or Sell?
Based on RV7’s technical indicators, RV7 is a Strong Buy.
    What is RV7’s RSI (14)?
    RV7’s RSI (14) is 56.80, which suggests RV7 is a Neutral.
      What is RV7’s MACD?
      RV7’s MACD is 0.55, which suggests RV7 is a Buy.
        What is RV7’s 5-day moving average?
        RV7’s 5-day moving average is 55.44, which suggests RV7 is a Buy.
          What is RV7’s 20-day moving average?
          RV7 20-day moving average is 55.35, which suggests RV7 is a Buy.
            What is RV7’s 50-day moving average?
            RV7’s 50-day moving average is 53.14, which suggests RV7 is a Buy.
              What is RV7’s 200-day moving average?
              RV7’s 200-day moving average is 50.40, which suggests RV7 is a Buy.
                What is RV7’s Williams % R (14)?
                RV7’s Williams % R (14) is -48.67, which suggests RV7 is a Buy.
                  What is RV7’s CCI (14)?
                  RV7’s CCI (14) is 46.30, which suggests RV7 is a Neutral.
                    What is the share price of Halozyme Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis